Corcept (CORT) trading halted, news pending; Bloomberg reporting the company has won FDA approval for its Korlym in Cushing's syndrome
Go back to Corcept (CORT) trading halted, news pending; Bloomberg reporting the company has won FDA approval for its Korlym in Cushing's syndrome| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 122.25 +1.20 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $121.05 | 52 Week High | $10.00 | |||
| Open | $121.48 | 52 Week Low | $3.22 | |||
| Day High | $123.44 | P/E | N/A | |||
| Day Low | $120.56 | EPS | $-0.46 | |||
| Volume | 656,438 | |||||
